Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer's disease.

Trushin S, Nguyen TKO, Ostroot M, Nesbitt JJ, Kovalenko T, Galkin A, Nambara T, Lu W, Kanekiyo T, Johnson G, Trushina E

Open source

DOI
10.1038/s44386-026-00072-3
Published
2026 Sep 2
Container
npj drug discovery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44386-026-00072-3,
  title = {Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer's disease.},
  author = {Trushin S and Nguyen TKO and Ostroot M and Nesbitt JJ and Kovalenko T and Galkin A and Nambara T and Lu W and Kanekiyo T and Johnson G and Trushina E},
  year = {2026},
  journal = {npj drug discovery},
  doi = {10.1038/s44386-026-00072-3},
  url = {https://doi.org/10.1038/s44386-026-00072-3}
}

RIS

TY  - JOUR
TI  - Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer's disease.
AU  - Trushin S
AU  - Nguyen TKO
AU  - Ostroot M
AU  - Nesbitt JJ
AU  - Kovalenko T
AU  - Galkin A
AU  - Nambara T
AU  - Lu W
AU  - Kanekiyo T
AU  - Johnson G
AU  - Trushina E
PY  - 2026
JO  - npj drug discovery
DO  - 10.1038/s44386-026-00072-3
UR  - https://doi.org/10.1038/s44386-026-00072-3
ER  - 

APA

S, T., TKO, N., M, O., JJ, N., T, K., A, G., T, N., W, L., T, K., G, J., & E, T. (2026). Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer's disease.. npj drug discovery. https://doi.org/10.1038/s44386-026-00072-3

Source records